Head and neck squamous cell carcinomas (HNSCCs) are highly aggressive, multi-factorial
tumors in the upper aerodigestive tract affecting more than half a million patients worldwide …

Simple Summary Even with recent advances, there are urgent needs for novel therapies to
improve overall survival and decrease toxicities in the management of head and neck …

Recent clinical trials have demonstrated a clear survival advantage in advanced head and
neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint blockade …

Artesunate, an anti-malarial drug, has been repurposed as an anticancer drug due to its
induction of cell death via reactive oxygen species (ROS) production. However, the …

Processes of intraoperative diagnosis and elimination of tumors or micro-tumors or cancer
cells or tumor micro environment (TME) with plasmonic nanobubbles (PNBS) are disclosed …

Oral squamous cell carcinoma (OSCC) is a highly aggressive cancer and the fourth leading
malignancy among males in Taiwan. Some pathogenic bacteria are associated with …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer
worldwide. To explore the genetic origins of this cancer, we used whole-exome sequencing …

Background The relative efficacy of the addition of induction chemotherapy to
chemoradiotherapy compared with chemoradiotherapy alone for patients with head and …

Inhibition of key molecules related to ferroptosis, cystine/glutamate antiporter and
glutathione peroxidase, may induce eradication of chemotherapy/radiotherapy-resistant …

Squamous cell carcinoma in the head and neck (HNSCC) is a common yet poorly
understood cancer, with adverse clinical outcomes due to treatment resistance, recurrence …